• Rat TNF-alpha protein (Recombinant) (C-His) (STJP001317)
  • Rat TNF-alpha protein (Recombinant) (C-His) (STJP001317)
  • Rat TNF-alpha protein (Recombinant) (C-His) (STJP001317)
  • Rat TNF-alpha protein (Recombinant) (C-His) (STJP001317)

Rat TNF-alpha protein (Recombinant) (C-His) (STJP001317)

SKU:
STJP001317

Current Stock:
Host: HEK293 cells
Reactivity: Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Rat TNF-alpha-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications.
Formulation: Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4.
Immunoreactivity: Measured in a cytotoxicity assay using L-929 mouse fibrosarcoma cells in the presence of metabolic inhibitor actinomycin D. The ED50 for this effect is typically 0.0125-0.05 pg/mL.
Gene Symbol: Tnf
Gene ID: 24835
Uniprot ID: TNFA_RAT
Immunogen Region: Leu80-Leu235
Immunogen: Recombinant Rat TNF-alpha Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Leu80-Leu235) of Rat TNFA (Accession #NP_036807.1) fused with an 6Ă—His tag at the C-terminus.
Post Translational Modifications The soluble form derives from the membrane form by proteolytic processing. The membrane-bound form is further proteolytically processed by SPPL2A or SPPL2B through regulated intramembrane proteolysis producing TNF intracellular domains (ICD1 and ICD2) released in the cytosol and TNF C-domain 1 and C-domain 2 secreted into the extracellular space. The membrane form, but not the soluble form, is phosphorylated on serine residues. Dephosphorylation of the membrane form occurs by binding to soluble TNFRSF1A/TNFR1. O-glycosylated.glycans contain galactose, N-acetylgalactosamine and N-acetylneuraminic acid. Tumor necrosis factor, soluble form: The soluble form is demyristoylated by SIRT6, promoting its secretion.
Function Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6. Promotes osteoclastogenesis and therefore mediates bone resorption. The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells.
Protein Name Tumor Necrosis Factor
Cachectin
Tnf-Alpha
Tumor Necrosis Factor Ligand Superfamily Member 2
Tnf-A Cleaved Into - Tumor Necrosis Factor - Membrane Form
N-Terminal Fragment
Ntf - Intracellular Domain 1
Icd1 - Intracellular Domain 2
Icd2 - C-Domain 1 - C-Domain 2 - Tumor Necrosis Factor - Soluble Form
Database Links Reactome: R-RNO-5357786
Reactome: -RNO-5357905
Reactome: -RNO-5357956
Reactome: -RNO-5626978
Reactome: -RNO-5668541
Reactome: -RNO-75893
Cellular Localisation Cell Membrane
Single-Pass Type Ii Membrane Protein
Tumor Necrosis Factor
Membrane Form: Membrane
Soluble Form: Secreted
C-Domain 1: Secreted
C-Domain 2: Secreted
Alternative Protein Names Tumor Necrosis Factor protein
Cachectin protein
Tnf-Alpha protein
Tumor Necrosis Factor Ligand Superfamily Member 2 protein
Tnf-A Cleaved Into - Tumor Necrosis Factor - Membrane Form protein
N-Terminal Fragment protein
Ntf - Intracellular Domain 1 protein
Icd1 - Intracellular Domain 2 protein
Icd2 - C-Domain 1 - C-Domain 2 - Tumor Necrosis Factor - Soluble Form protein
Tnf protein
Tnfa protein
Tnfsf2 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance